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Many details of the path~genesis of th.e human imJ?unodefi-
ciency virus type 1 remalll to be eluCidated. DetaIls of how 
the virus gains entry via the mucosal surface upon sexual 
contact or during breast feeding remain obscure. The means 
by which the infection travels throughout the body as well as 
the nature of the major reservoirs of virus infection remains, 
for the most part, unknown. 
Recent studies raise the possibility that cells of the Langer-
hans/ dendritic lineage play a ce~tral role in human iJ?muno-
deficiency virus (HIV -1) lllfectlon and pathogeneSIs. It has 
been known for several years that veiled dendritic cells in the 
circulation as well as skin Langerhans are infected in people 
with prolonged HIV -1 infections. More recently it has been 
found that a large burden of viral DNA sequences is found, 
not only in the circulating T-cell population, but also in 
a population that is defined as a non-T, non-B, non-
monocyte/macrophage population rich in T -helper den-
dritic cells. 
Detailed analysis of infection of primary blood - derived 
T -helper dendritic cells by HIV -1 shows that such cells ar:e 
the most susceptible cells in the blood to infection by tlllS 
H uman immunodeficiency virus (HIV-1) is a sex-ually transmitted disease [1]. Recent studies using the simian immunodeficiency virus (SIV) show that transmucosal infection occurs following exposure of intact male and female sexual mucosa to concen-
trated solutions of cell-free virus [2]. Other studies show that chil-
dren of infected mothers can also be infected through breast feeding 
[3]. The observation that a potent class of antigen-presenting cells, 
cells of the Langerhans/dendritic cell lineage, are abundant at the 
surface of the oral and sexual mucosa raises the possibility that these 
cells constitute a site of primary infection by the virus. What fol-
lows is a brief review of salient features of cells of this lineage as well 
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virus . The cells also produce much more virus per cell than do 
purified populations of other blood mononuclear cells. More-
over, primary blood-derived T-helper dendritic cells are not 
killed by infection by HlV -1. These cells are susceptible to 
lymphotropic, monocyte tropic, and primary isolates of 
HIV-1. 
The sensitivity of primary blood-derived T-helper den-
dritic cells to infection by HIV -1 has been shown to be attrib-
utable to rapid uptake of virus particles as well as rapid synthe-
sis of viral DNA. Subsequent steps of virus replication also 
occur more rapidly and more efficiently in populations of 
primary blood - derived T -helper dendritic cells than they do 
in purified preparations of blood-derived T cells and mono-
cyte / macrophages. 
Studies with primates using the simian immunodeficiency 
virus (SIV) show that dendritic cells at the surface of sexual 
mucosa are rapidly infected upon exposure to high concen-
trations of the virus. SIV is also produced in abundance in 
Langerhans cells located at the surface of the sexual mucosa in 
animals infected for prolonged periods of time. ] Invest Der-
rnato/99:89S-94S, 1992 
as a summary of what is known regarding infection of Langerhansj 
dendritic cells in HIV-1-infected people and in cell culture. 
THE LANGERHANSjDENDRITIC CELL LINEAGE 
Accessory dendritic cells constitute at least four (Table I) cellular 
comp~r.tments (excluding dendritic epidermal T cells). Maturing 
dendntlc cells are found as Langerhans cells in squamous epithelia, 
intestinal mucosa [4], airways, bile ducts, and interstitially in kid-
neys and hearts [5,6]. The migratory compartment of dendritic cells 
include the circulating veiled and blood dendritic cells in lymph and 
blood and interdigitating dendritic cells in the T-cell dependent 
areas of the lymphoid organs engaged in stimulation and growth of 
selected T cells from the circulating T-cell pool [7,8]. In the B-cell-
dependent areas a different type of cell, called the follicular den-
dritic cell, traps antigen-antibody complexes and forms tight clus-
ters with B cells [9]. The follicular dendritic cells play an important 
role in B-cell memory [9] . There is good evidence that the Langer-
hans cells in the epidermis, dendritic cells in the circulation (migra-
tory dendritic cells), and dendritic cells in paracortical T-cell areas 
of the lymph nodes (interdigitating dendritic cells) are closely re-
lated to one another [7,10]. The Langerhans cells are found to mi-
grate from the epidermis to the lymphoid organs [7,11]. It is not 
clear where in development the differentiation pathway that leads 
to the formation of follicular dendritic cells diverges from that 
which leads to development of Langer hans as well as circulating and 
interdigitating dendritic cells. It is clear that these two types of cells 
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Table I. Dendritic Cells 




Blood and Lymph 
Blood dendritic cells 
Veiled dendritic cells 
Lymphoid Organs 
Interdigitating dendritic 
cells (T -cell areas) 
Follicular dendritic cells 
(B-ce II areas) 
rerform distinct functions and differ in expression of selected genes 
[7]. Table II summarizes the differences in cell markers between 
blood dendritic cells (DC), Langerhans cells (LC), follicular den-
dritic cells (FDC), and monocytes. 
The common feature of all dendritic cells are their veiled pheno-
type, minimal phagocytic activity, and potent accessory cell func-
tion for stimulation and nurture ofT cells and B cells [7,9,12]. 
The evidence for infection by HIV -1 of the blood dendritic cells 
as well as infection of other types of dendritic cells is summarized 
below. 
HIV-1 INFECTION OF MIGRATORY 
DENDRITIC CELLS 
The blood-derived T -helper dendritic cells from HIV -1- infected 
individuals contain significant amounts of HIV-1 viral DNA 
[13,14,15], and viral budding has been demonstrated from dendritic 
Table II. Differences in Cell Markers Between Blood 
Dendritic Cells, Langerhans Cells, and Follicular Dendritic Cells 
Follicular 
Dendritic Langerhans Dendritic 
Determinant Cells Cells Monocytes Cells 
MHC 
Class I +++ +++ ++ + 










CDt4 +++ + 
CR, FcyR 
CRt CD35 NO' ND + + 
CR2 CD2t + 
CR3 CDttb (c3bi) + + + + 
CDt6 (FcRIlI) NO 
CD23 (FcE) + + 





CD40 + + 
NK cell markers 
CD 56 
CD57 
IL-2R + + 
Common Leukocyte 
Marker 
CD45 + + + 
Adhesion molecules 
COl la + + + 
CO tS + + 
VCAM-t + + + 
ICAM-t + + + + 
VLA-p-t + NO + + 
'N ot determined. 
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Figure 1. Genetic organization of HIV-1. 
cells isolated from patients [131. A recent study has found less pro-
viral DNA in partially enriched cultures of dendritic cells from 
seropositive individuals as compared to purified cultures of 
CD4-positive T cells from the same individuals (Cameron PU, 
Forsum U , Teppler H, Granelli-Piperno A, Steinman RM: During 
HIV-1 infection most blood dendritic cells are not productively 
infected and can induce allogeneic CD4+ T cells clonal expansion. 
Clin Exp Immunol 88:226-236, 1992). Blood-derived T-helper 
dendritic cells express the CD4 molecule, the receptor for the HIV-
1 virus, as shown by immunoperoxidase and by immunogold elec-
tronmicroscopy (EM) studies [14,161. The expression of CD4 on 
blood dendritic cells and Langerhans cells is enhanced by y inter-
feron [14,171. 
The studies of Langhoff et al (1991) have shown that blood 
dendritic cells in vitro are highly sensitive to infection with HIV-1 
and support severalfold more viral production than infected bulk T 
cells, CD4+ T cells, or monocytes [18]. Purified dendritic cells 
support prolific growth of both monocytropic and T-cell tropic 
isolates of HIV -1 as well as primary patient isolates [18]. 
REPLICATION OF HIV-1 IN MIGRATORY 
DENDRITIC CELLS 
The basis for preferential infection and the high yield of virus pro-
duction from cultures of primary blood -derived T -helper dendritic 
cells infected with HIV -1 has been investigated (Langhoff et ai, 
submitted). Figure 1 shows the general genetic structure of the 
proviral form of HIV -1 and summarizes the function of the differ-
ent viral genes expressed in infected leukocytes . The HIV -1 pro-
virus encodes three structural genes, gag, pol, and epw. The gag en-
codes viral structural core proteins. The pol gene encodes products 
necessary for synthesis of viral DNA, RNA-dependent DNA po-
lymerase, and RNAse H. The amino terminus of pol specifies the 
protease and enzYI?es requir.ed for corre~t capsid protein processing. 
The carboxy termmus of tillS open readmg frame specifies the inte-
grase protein, an enzyme required for insertion of viral DNA se-
quences into the host genome. Env encodes proteins that are em-
bedded in the viral outer lipid of the virus molecule (gp120 and 
gp41) and that determines the specific receptor interaction with the 
CD4 molecule on target cells. 
In addition to the genes that encode virion proteins the genome 
of HIV -1 specifies at least six additional regulatory genes (tat, rev, 
nif, vif, vpr, and vpu) [191. The tat gene encodes a transactivator 
function [20,21]. The tat protein binds to the 5' end of the nascent 
RNA transcripts and accelerates the rate of initiation of mRNA as 
well as increasing the processivity of RNA polymerase that tran-
scribes the HIV-l mRNA. Rev encodes a protein that binds to a 
sequence in the 3' portion of the primary mRNA transcript and 
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Figure 2. HIV-l life cycle in infected cell s. 
rmits nuclear export of unspliced and singly spliced mRNAs from 
fhe nucleus. In the absence of rev activity only multiply spliced 
rnRNAs reach the cytoplasm, where they are translated [22,23]' 
Both tat and rev are essenti~1 g~nes for.viral growth in I~mphocytes. 
The nef coding exon begms Immediately after the 3 end of etlV 
[24,251. Recent evidence i~dicates that tlef ma~ be necessary for 
rolific replication in the pnmary cells [25] and m the natural host 
f26]. I h . C • • fl ' . Vif encodes a product t lat en ances Imectlvlty 0 t Ie viruS parti-
cle [27,28] . Vpr [29,30] ma~es a prot~in that 5s f~)Un? in the v.irus 
particle itself. Vpr .is not reqUired for ViruS ~eph~atlOn I~ T -cellimes 
but does permit VIruses to grow more rapidly 111 a vanety of other 
cell types [31]. Vpu facilitates virus assembly and export,l32]. 
The functions of these genes, tat, rev, vpu, vpr, /leI, vi[, and the 
regulatory elements of tl~e.l~ng terminal rep~at (L ~R), I~ave been 
determined in rapidly dlvldmg tumor cell hnes. Little IS known 
regarding the function of these genes in subsets of primary leuko-
cytes. It was recently shown that a virus defective for expression of 
vpr, vpu, and neI replicates in primary cultures of blood T -helper 
dendritic cells [18]. 
Figure 2 illustrates the virus. life cycle ~n infected dendritic cells. 
The viral envelope glycoprote111 gp120 bmds to the CD4 molecule 
of the target cell and fuses with the cell membrane. Upon cell entry 
the viral RNA is converted to a double-stranded viral DNA form. 
This is a multistep process and includes binding of the tRNA 
primer, synthesis of DNA to the end of t.he 5' R region, tem~late 
switching to the 3' end, and an elongatIOn of the strand (mulUs 
strand) to the 5' primer binding site. The synthesis of the 5' L TR is 
initiated from the 3' end of the minus strand DNA, and a second 
template switching followed by DNA-dependent polymerization 
occurs to complete the double-stranded DNA [33]. In dendritic cells 
this process occurs rapidly and completely. The synthesis of the 
double-stranded DNA in infected primary T-helper dendritic cells 
is completed by 20 h post-infection, much more rapidly than occurs 
in infected primary T cells and monocyte/macrophage cultures. 
The newly made linear DNA duplex migrates to the nucleus. It is 
the precursor for integration. The stable association of viral and host 
genetic DNA is achieved by covalent linkage of the provirus DNA 
and the host DNA. 
The linear virus DNA can also form several types of DNA circles 
within the nucleus. One type of circle contains two L TRs joined 
together end-to-end. A second type of circle contains only a single 
L TR formed by homologous recombination between the identical 
L TR sequences, which flank the full-length genome (for details see 
[16,33]). The importance of the circular forms for viral replication 
in the non-dividing dendritic cells is not known for HIV -1. For 
visna virus it is reported that the unintegrated forms are transcrip-
tionally active [34] . Circular forms ofHIV-1 have been shown to 
arise from superinfections of infected cells and may contribute to 
cytopathicity [35,36]. Infected cultllres of dendritic cells and Lan-
gerhans cells show little cytopathic changes [18,37]. Viral mRNA is 
produced from integrated proviral copy. 
Studies have been undertaken to determine the kinetic appear-
ance of the viral mRNA transcripts in dendritic cells compared with 
the events of viral DNA synthesis and integration (Langhoff, Kal-
land, Haseltine, submitted). Table III shows the kinetics of viral 
reverse transcription, and viral mRNA expression in dendritic cells 
and T cells. Virus uptake and virus DNA synthesis in primary den-
dritic cells occurs rapidly and efficiently. Full-length copies of viral 
DNA appear in infected dendritic cells many hours before they 
appear in infected T cells. Viral mRNA species also appear in den-
dritic cells well before they appear in culture of infected primary T 
cells. The prolific virus replication at the molecular level in den-
dritic cells is remarkable because the high level of virus replication 
occurs in cells that are terminally differentiated and do not replicate 
[7]. 
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Table III. Molecular Growth of HIV -1 in Blood Dendritic 
Cells and T Cells 
Complete Reverse Viral mRNA 
Transcription Production 
<20 h 40 h <20 h 40 h 
Dendritic cells + + + + 
T cells + (+) 
HIV-l INFECTION OF LANGERHANS CELLS 
The first evidence that HIV -1 could infect cells of Langerhans/ 
dendritic cell lineage was the work of Tschachler and Stingl and 
their colleagues [38,39) . These workers reported (39) that 2-5% of 
Langerhans cells in the skin of HIV -1- positive individuals are in-
fected by HIV-l as judged by immunocytochemistry and EM. 
These Langerhans cells were HIV-t culture positive [37,40) . A 
reduced number of Langerhans cell s in the skin has also been re-
ported in HIV -1 infected individuals, but this finding is controver-
sial [41,42). Recent studies of detection of proviral HIV-l DNA by 
the polymerase chain reaction (PCR) has confirmed that HIV-1 
infects Langerhans cells in skin [38,43,44). Budding of mature virus 
from partially purified Langerhans cells infected in vivo has been 
shown by electronmicroscopy (40) . By contrast Kalter et al (45) and 
Kamitaki et al (46) do not find evidence of infection in skin Langer-
hans cells by HIV-1. 
Studies of genital mucosal transmission of SIV macaques have 
shown that SIV infection is initiated when the virus is applied in 
high concentration to the sexual mucosa of male and female mon-
keys [2,47 ,48]. Miller et al find SIV antigens in cells resembling 
mucosal Langerhans cells shortly after application of virus to the 
mucosal surface. The viral antigens are initially concentrated in this 
type of cell. By iI' situ hybridization mucosal Langerhans cell s be-
came infected with SIV after mucosal exposure [48]. The virus doses 
required for mucosal infection are reported to be a thousandfold 
higher than those for intravenous infection (2). Mucosal transmis-
sion is also known to occur for lentiviruses (visna-maedi) in sheep 
(49) . Transmission of HIV-l by breast feeding of infants has also 
been proposed by Van de Perre et al [3] to occur at a rate of36% from 
seropositive mothers. 
It is thought that Langerhans ce ll s in the skin undergo a process of 
maturation in the epidermis and migrate during this process via the 
dermis to the lymphatics and subsequently to the draining lymph 
nodes in the T-cell-dependent areas and/or through blood capil-
laries to the circulation [11). Once infected in the mucosa, migra-
tion of infected cells may spread the infection to T cells in the lymph 
nodes. Recent studies in fact find a severalfold higher virus load in 
lymphoid tissue as compared to peripheral blood leukocytes [50]. 
HIV-l INFECTION OF FOLLICULAR 
DENDRITIC CELLS 
The follicular-dendritic cells form a distinct subgroup of the den-
dritic cells localized exclusively in the lymr.hoid follicles of which 
the B cells form the major cell component 19 ,51,52]. The follicular 
dendritic cells represent 2% of the total cell population of the folli-
cl es. In contrast to other dendritic cells, follicular dendritic cells are 
not thought to be bone marrow derived [53] and lack the common 
leukocyte marker (CD45) but have some surface markers in com-
mon with B cells (CDI9) and monocyte/macrophages (CD14) 
[51 ,54]. Single cell isolates of follicular dendritic ce lls do not have 
surface CD4 expression [55,56] or mRNA for CD4 (Table II) [55]. 
One prominent function of follicular dendritic cells is their capac-
iry to trap and retain antigen-antibody complexes on the long cyto-
plasmic extension by Fc and C3 receptors, and present these com-
plexes to B cells [9,51,57,58]. The antigen-antibody complexes are 
not endocytosed and are retained for prolonged periods of time 
[9,59) . Follicular dendritic cells do not participate in the primary 
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lymphocyte activation, they only retain antigen when specific anti-
bodies are present. However, follicular dendritic cells accelerate the 
emergence of functional memory B cells and high-affiniry antibod-
ies [59] . Follicular dendritic cells also trap activated B cells in the 
germinal center by binding of the VLA-4 molecule on the B cells to 
NCAM-110 on follicular dendritic cells [60] . 
Early studies of retroviral infection of follicular dendritic cells 
have shown that these cells are infectable by Abelson leukemia virus 
and Rauscher leukemia virus [61,62] and with feline leukemia virus. 
HIV-l virus particles were found associated with follicular den-
dritic cells in people with lymphadenopathy [63,64]. The virus 
particles were mainly found sequestered extracellularly in the laby-
rinth of the follicular dendritic cells [54,63] with occasional forma-
tion of virus suggestive of virus budding [64,65]. Subsequent studies 
[65 - 68] have demonstrated deposition of viral protein within the 
germinal centers primari ly within the extracellular deposits of im-
mune complexes. These studies do not rule out the possibiliry that 
the viral antigens were passively trapped as immune complexes 
arriving from remote extranodal sites. The functional importance of 
the trapping of antigen-antibody complexes is at present specula-
tive. Klaus et al [59] have shown highly enhanced immunoglobulin 
responses when immunizing mice with antigen-antibody com-
plexes rather than native antigen. The authors speculate that admin-
istration of HIV -1 antigens as a complex with the antibody targets 
the viral antigen to the follicular dendritic cells rather than to the 
cells of the monocyte/macrophage lineage. This may present one 
mechanism for the HIV -1- induced polyclonal B-cell activation 
and hypergammaglobulinemia in HIV -1- infected individuals [69]. 
A more definitive proof for an active virus replication in the 
germinal centers and in the follicular dendritic cells has been demon-
stration of mRNA by in situ hybridization [70,71]. Recent in vitro 
studies have also shown that highly purified (> 90%) preparations 
of single-cell follicular dendritic cell s are highly infectable by 
HIV-1 using the PCR for detection of HI V-I DNA 4 d after infec-
tion [56). In this case the lack of expression of the CD4 molecule by 
follicular dendritic cells was not limiting for the HIV -1 infection, 
which was also insensitive to pretreatment with anti-CD4 antibod-
ies. The route of entry of the HIV -1 virus is unknown. An antibody 
mediated entry of the virus via the Fc-receptors of the follicular 
dendritic cells is not likely because the fo llicular dendritic cells 
retain antigen-antibody complexes on the surface [59]. HIV-1 in-
fection of CD4-negative cells is reported to occur for certain neuro-
nal, muscle, and intestinal cell s [72,73). The capaciry of fo llicular 
dendritic cells to support long-term cell lines production is not 
determined. 
In vivo infection with HIV -1 has profound effects on the architec-
ture of the germinal centers. Early infection is characterized by 
follicular hyperplasia and disruption of the fine dendritic cell net-
work in the follicles. With progress of the disease (follicle degener-
ation) fo llicular dendritic cells disappear and are absent in the late 
stage of HIV-l infection (depleted stage) [68,71,74,75]. These in 
vivo studies raise the possibiliry that HIV -1 is cytopathic for follicu-
lar dendritic cells. 
SUMMARY 
These studies permit us to speculate that HIV is primarily an infec-
tion of the Langerhans/dendritic cell lineage. Cells of this lineage 
may provide the primary point of entry of the virus during sexual 
contact and breast feeding. Mobile Langerhans cells may permit the 
virus to travel from the site of primary infection to the lymph nodes 
and thence to the circulation. The circulating T-helper dendritic 
cells may provide a primary reservoir of HIV-1 infection. Virus-
producing Langerhans cells at the surface of sexual mucosa may 
shed virus into seminal and vaginal fluids. Viewed from this per-
spective, infection and destruction of the CD4+ T-cell population 
by HIV -1 may be an unfortunate secondary consequence of a pri-
mary infection of the Langerhans/dendritic cell lineage. 
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